Meyer, T., Ichikawa, I., Zatz, R
Critical pricing verification - the NextMed precedent: In December 2025, the FTC finalized an enforcement action against a GLP-1 telehealth company (NextMed) partly because it advertised a monthly membership price that did not include the actual cost of the GLP-1 drug, lab work, or provider consultation fees
just one dissolvable tablet a day
Total: 4-8 business days from approval to your door
Retatrutide Why CagriSema Works: Lessons for Potential Retatrutide Combinations The success of cagrilintide and semaglutide (CagriSema) in clinical trials offers insights that might apply to cagrilintide dosage with retatrutide scenarios [17]: CagriSema Success Factors: Complementary mechanisms Amylin (cagrilintide) and GLP-1 (semaglutide) work through different pathways Overlapping but manageable side effects Both cause GI effects, but titration protocols minimize discontinuation Synergistic efficacy 22.7% weight loss exceeds either compound alone Single pharmaceutical developer Novo Nordisk controls both compounds, enabling coordinated development Key Differences with Retatrutide: The additional receptor targets with retatrutide create both potential advantages (broader metabolic effects) and concerns (more complex interactions, potentially greater side effects)
Administration of 5-FU resulted in severe iron deposition in small and large intestinal stained tissues (Fig